Masitinib is being investigated in the treatment of amyotrophic lateral sclerosis (ALS) The Wall Street Journal, 4 Nov 2013 Accessed on 6 Nov 2013 from http://online.wsj.com/article/PR-CO-20131104-908831.html?dsk=y. CommentRecommendBookmarkWatch